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Traditional options in managing failed trabeculectomy (bleb needling, revision, additional incisional surgery and tube surgery)
have a relatively high failure and complication rate.The use of microinvasive glaucoma surgery (MIGS) has generally been reserved
to mild to moderate glaucoma cases, proving good safety profiles but significant limitations in terms of efficacy. We describe a
patient who underwent MIGS (XEN Aquesys subconjunctival shunt implantation) after a prior failed trabeculectomy. After the
surgery, the IOP was well controlled but as the stent was close to an area of scarred conjunctiva of the previous trabeculectomy, it
became partially exposed. As a complete success was achieved, we decided to remove the conjunctiva over the exposed area and
replace it by an amniotic membrane transplantation and a conjunctiva autograft. Six months after surgery, the unmedicated IOP is
still well controlled with complete visual acuity recovery.
1. Introduction
Despite its widespread use, trabeculectomy has some limita-
tions. Aside from short-term problems such as a near 50%
rate of transient perioperative complications [1], the long-
term rate of failure has been reported to be as high as 50%
at 5 years, even with adjunctive 5-FU orMMC, as reported in
“the tube versus trabeculectomy study” [2].
The main causes of a failed trabeculectomy are episcle-
ral or subconjunctival fibrosis [3, 4]. When a trabeculec-
tomy procedure fails, subsequent procedures may include
needling, a second trabeculectomy, or placement of a tube
shunt. All of these procedures have potential complications
and are generally reported to have a higher failure rate than
primary trabeculectomy [5].
The use of microinvasive glaucoma surgery (MIGS) has
generally been confined to mild to moderate glaucoma cases,
often in combination with cataract surgery, and not in more
severe glaucoma patients (especially if they have undergone
previous glaucoma surgery) [6].
While other MIGS devices target Schlemm’s Canal and
the suprachoroidal space, the XEN subconjunctival stent is
theworld’s first ab internoMIGS approach to subconjunctival
outflow.
During surgery, the 6mm gelatin stent is preloaded into a
disposable injector with a 27-gauge needle. The stent creates
a permanent patent channel through the sclera allowing
aqueous humor to flow from the anterior chamber to the sub-
conjunctival space. A sub-2mm clear cornea main incision is
used for the procedure. The injector enters the incision and
travels across the eye to the superior nasal quadrant where the
stent will be placed.TheGel Stent is delivered by actuating the
slider on the one handed injector.
Once in place, the outflow is regulated by the physics of
the internal stent lumen.
Here, we report the case of a patient with a long-term
failed trabeculectomy and a badly scarred superior bleb, who
was subsequently implanted with the subconjunctival XEN
stent.
The stent was placed nasally to the area of the previous
bleb. Despite being successful in reducing pressure, the stent
became exposed due to extremely thin and weak conjunctiva
and also due to the nasal location. This case briefly explains
how we rescued the surgery, by patching the stent with
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Figure 1: The internal bore of the stent is clearly visible into the
anterior chamber.
amniotic membrane and a graft of conjunctiva. Six months
after surgery, the IOP is under control without medications.
2. Case Report
S.A. is a 51-year-old Caucasian male who underwent a trabe-
culectomy in his left eye in 2004 at another center. He is a
high myope, −11.5 spherical equivalent, with a visual acuity
of 0,4. In October 2014, he presented a severe visual field
damage, with a mean deviation (MD) of −21.65 dB and a
pattern standard deviation (PSD) of 11.04 dB (Humphrey 24-
2 SITA Standard, Carl Zeiss Meditec, Inc., Dublin, CA). His
IOP remained under control with maximal tolerated medical
therapy until October 2014, at which point his IOP rose
above 26mmHg on a number of occasions, and he was ulti-
mately scheduled for secondary surgery approach. Due to his
previous complicated trabeculectomy, the patient requested
a less invasive approach and XEN surgery was proposed.
In November 2014, he underwent an uncomplicated XEN
surgery. Due to the presence of a scarred conjunctiva in
the superior quadrants, the stent was implanted in the nasal
quadrant at 9.30 o’clock rather than the usual 11 o’clock posi-
tion.This abnormal positionmay have ultimately contributed
to the exposure because the XEN stent is less protected by the
superior eyelid. Other than that, it appeared to be a successful
XEN surgery.
On the first postoperative day, the bleb was well formed,
the IOP was 6mmHg, and the visual acuity was only lightly
reduced to 0,3. The stent appeared well placed both subcon-
junctivally and at the gonioscopic examination (Figure 1).
One week postop, the IOP remained in the low teens and
visual acuity fully recovered.
At the 15 days’ postoperative exam, the stent appeared
exposed. The visual acuity was stable, but IOP was lower
than 4mmHg.Theanterior chamberwaswell formedwithout
signs of inflammation and therewas no choroidal detachment
(Figure 2).
We then determined to bring the patient back in for a
rescue surgery. The patient underwent an amniograft with
autologous conjunctival transplantation. Careful dissection
of a large area of conjunctiva, from 7 to 11 o’clock, was done
in the area where the stent was implanted.
Figure 2: 15 days after surgery, the stent was exposed in its terminal
part.
Mild diathermy was performed over the area to avoid
excessive bleeding (Figure 3(a)).
The amniotic membrane folded twice keeping the epithe-
lial side in the middle and was implanted over the area and
sutured at the limbus with 10-0 nylon (Figure 3(b)).
The inferotemporal conjunctiva was then ballooned,
injecting lidocaine to harvest the conjunctival graft which
was sutured over the amniograft with interrupted 10-0 nylon
sutures (Figures 3(c) and 3(d)).
After surgery, the patient was kept on local antibiotics and
steroids.
One day later, the bleb was formed, visual acuity was
0,2, and IOP was 13mmHg. By one week, his previous visual
acuity had recovered.
The patient was followed weekly during the next month
with IOP in the low teens without antiglaucomamedications.
Over the next 6 months, the patient presented with a
pressure constantly lower than 14mmHg and a stable visual
acuity.
More than six months after surgery, the IOP is still under
control without medications and the stent is well covered
(Figure 4). At the last visual field performed, in May 2015, he
presented a MD of −21.91 and a PSD of 10.98.
3. Discussion
Trabeculectomy is considered the standard technique for
lowering intraocular pressure in glaucoma patients. In its
modern version, its success rate is generally high despite
being dependent on the postoperative follow-up.As time pro-
gresses after surgery, however, failure of filtration is relatively
common and the management of a late failed filtering bleb is
controversial.
Despite being generally advocated for early failure and
needling as well as trabeculectomy revision, a second tra-
beculectomy or a tube implant is potential option.
With the exclusion of tube surgery, all anterior proce-
dures, nevertheless, present a higher failure rate if compared
to primary trabeculectomy.
Currently, there is no evidence based approach to a late
failed bleb and the choice of surgery is influenced by the
personal surgical experience as well as by the clinical appear-
ance.
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Figure 3: (a) A large area of conjunctiva surrounding the stent was excised and mild diathermy was applied over the scleral area. (b) A
double layer of amniotic membrane was sutured over the dissected area. (c) After ballooning the conjunctiva with lidocaine, a larger patch of
conjunctiva was excised in the inferotemporal quadrant to serve as a graft. (d) The graft was sutured over the amniotic membrane with 10-0
nylon interrupted sutures.
Figure 4: The bleb as it appears 6 months after surgery. A deep
suture that could not be easily removed is still visible under the
conjunctiva.
In this case report, we decided to take a new approach.
Our decision was founded on previous unfortunate experi-
ence of the patient who reported to have lost several lines of
visual acuity following trabeculectomy.
We proposed a less invasive approach by implanting a
XEN stent and the patient agreed.
Trabecular surgery might have been another choice, but
the range of pressure would have been in the midteens and
our previous experience with trabecular surgery in failed
trabeculectomies had generally been poor.
Although our follow-up is relatively limited, the use
of XEN stent in failed trabeculectomies and our grafting
techniques are both quite promising. Our case shows that
XEN stent may be successful in patients with a late failed and
scarred bleb. It also points out that if the implant is placed
too close to the scarred tissue, too nasal, or too short, it may
become exposed.
A recent Cochrane report [7] has examined the different
strategies to seal a bleb leak. Out of 1333 reports, only a
single study was selected for analysis, indicating that there
is no clear evidence on the superiority of a single interven-
tion. This study randomly compared amniotic membrane
transplantation to conjunctival advancement and indicated
a clear advantage of the latter. In our patient, conjunctival
advancement would have been difficult due to the presence
of scarred conjunctiva and we selected a mixed approach by
transplanting a large and double patch of amnioticmembrane
to be a scaffold for a free conjunctival graft. The amnion
presents anti-inflammatory properties and growth factors
that prevent or decrease fibrosis in healing tissue [8].
The XEN implant was successful in lowering the IOP in
the low teens and its minimal impact on the globe anatomy
still allows other surgical options.
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Because traditional glaucoma surgeries can have a limited
life span and have potentially serious complications, we
believe that minimally invasive surgeries may play a role in
widening the sight spectrum of glaucoma patients.
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